Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone vs Fluticasone-Azelastine in Allergic Rhinitis
NCT07415278Phase 4Active, not recruiting
- Sponsor
- Pamukkale University
- Start
- Dec 2022
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of azelastine + fluticasone in allergic rhinitis (AR), sponsored by Pamukkale University. Started Dec 2022; status: active, not recruiting.
02
Drugs
azelastine + fluticasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT07415278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07415278.